Deep phenotyping of manufactured enhanced-affinity NY-ESO-1-specific T cells reveals a pattern of effector and memory programming that correlates with clinical outcome in observed cancer indications Meeting Abstract


Authors: Melchiori, L.; Lowther, D. E.; Binder-Scholl, G. K.; Williams, D. D.; Peretz, Y.; Fortin, M.; Tap, W. D.; Rapoport, A. P.; Mackall, C. L.; Jakobsen, B. K.
Abstract Title: Deep phenotyping of manufactured enhanced-affinity NY-ESO-1-specific T cells reveals a pattern of effector and memory programming that correlates with clinical outcome in observed cancer indications
Meeting Title: 19th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
Journal Title: Molecular Therapy
Volume: 24
Issue: Suppl. 1
Meeting Dates: 2016 May 4-7
Meeting Location: Washington, DC
ISSN: 1525-0016
Publisher: Nature Publishing Group  
Date Published: 2016-04-01
Start Page: S75
Language: English
ACCESSION: WOS:000375264200190
PROVIDER: wos
DOI: 10.1016/S1525-0016(16)33202-6
Notes: Meeting Abstract: 192-- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William Douglas Tap
    372 Tap